First commercial launches expected during 2015
London, UK – 24 March 2015 – NetScientific (AIM: NSCI), the biomedical and healthcare group, announces its results for the year ended 31 December 2014. Highlights were as follows:
Sir Richard Sykes, Executive Chairman of NetScientific said:
“2014 has been a productive year for NetScientific, focusing on the growth plans of our lead portfolio companies, as well as seeking new investments, and establishing and building relationships with strategic partners.
In 2015, we anticipate commercial launches from our core portfolio companies, Wanda Health and Vortex BioSciences, further enhancing the value of our portfolio.
Post year end, we initiated a review of our portfolio and strategy and we will report the results by mid-year 2015.”
For the full release, please click here.
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society. For more information, please visit the website at www.NetScientific.net
Issued for and on behalf of NetScientific by Instinctif Partners.
For more information please contact: email@example.com